2163793-38-0 (PROTAC Mcl1 degrader-1 | PROTAC,PROTAC Mcl1 degrader-1)

PROTAC Mcl1 degrader-1;BDBM50505351;N'-[2-[6-(4-bromophenyl)sulfanyl-1,3-dioxobenzo[de]isoquinolin-2-yl]ethyl]-N-[6-[[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindol-4-yl]amino]hexyl]hexanediamide;EX-A8619;AKOS040733695;Mcl-1 Degrader C3;HY-125877;N'-(2-{10-[(4-bromophenyl)sulfanyl]-2,4-dioxo-3-azatricyclo[7.3.1.0,5,13]trideca-1(13),5,7,9,11-pentaen-3-yl}ethyl)-N-(6-{[2-(2,6-dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]amino}hexyl)hexanediamide;DA-57148;EN300-7550529;G16997;CHEMBL4460727;CS-0102617;2163793-38-0;MS-31699;

BORXNUWYWZOREQ-UHFFFAOYSA-N

1S/C45H45BrN6O8S/c46-27-15-17-28(18-16-27)61-35-21-19-32-39-29(35)9-7-10-30(39)42(57)51(43(32)58)26-25-49-37(54)14-4-3-13-36(53)48-24-6-2-1-5-23-47-33-12-8-11-31-40(33)45(60)52(44(31)59)34-20-22-38(55)50-41(34)56/h7-12,15-19,21,34,47H,1-6,13-14,20,22-26H2,(H,48,53)(H,49,54)(H,50,55,56)

BrC1C=CC(=CC=1)SC1C=CC2C(N(C(C3=CC=CC=1C=23)=O)CCNC(CCCCC(NCCCCCCNC1=CC=CC2C(N(C(C=21)=O)C1C(NC(CC1)=O)=O)=O)=O)=O)=O